We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Technology for Respiratory Care

By HospiMedica staff writers
Posted on 11 Mar 2005
New technology utilizes heat and capillary action to rapidly turn liquid into vapor and is expected to lead to improvements in respiratory and humidification treatments.

About the size of an aspirin tablet, the technology was initially developed for camping stoves due to its ability to turn liquid fuel into vapor and release it with a high-velocity jet action. More...
The resulting vapor is more readily usable because it is a true vapor, meaning that liquid droplets are not created during the process and therefore do not need to evaporate before a vapor is formed. Also, the technology does not utilize moving parts, so there are no complicated, breakable components.

The technology, called capillary force vaporizer, was created by Vapore, Inc. (Richmond, CA, USA). The vaporizer is made of ceramic discs. When liquid is supplied at the bottom of the discs, capillary forces lift the liquid through the discs, similar to the way water is brought to the top of a tree. Heat is then applied to the top of the discs and phase transition turns the liquid into a vapor that is released through an opening.

Vapore is working with original equipment manufacturers (OEMs) on developing first-generation products utilizing the technology. PARI Innovative Manufacturers (Midlothian, VA, USA) has licensed the technology for use in respiratory care worldwide. In testing, PARI and Vapore engineers were able to create a humidifier that generated vapor in two or three seconds and was the size of a D battery. The test was extremely efficient with a 93% energy-use rating. PARI sees the eventual use of this technology for hospital ventilators, infant incubators, and other applications.

"We are pleased to partner with Vapore, Inc. to bring this new technology to the medical community and look forward to partnering with pharmaceutical companies and device manufacturers to further improve breathing and humidification treatments,” said Werner Gutmann, president and CEO of PARI.





Related Links:
Vapore
PARI

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.